Purpose: To determine the diagnostic yield of transjugular liver biopsy (TJLBx) samples to evaluate for infectious etiology (immunosuppressed protocol [ISP] of TJLBx) in bone marrow transplant (BMT) recipients.
Methods: A retrospective review of 78 TJLBx in 61 patients who had undergone BMT was undertaken. Biopsy was performed with an automated 19-gauge needle set. The primary indication was suspected graft-versus-host disease in all; a subset also sought to detect infectious liver pathology. In these (n = 31 biopsy samples, 22 patients), an ISP was used with tissue sent for bacterial, viral, fungal, and mycobacterial analysis in addition to histology. In the remainder (n = 47 biopsy samples, 41 patients), tissue was sent for histology only (H). Sample adequacy, histological diagnosis, microorganism assay results (ISP), and complications were reviewed. To assess sample adequacy in BMT compared to non-BMT patients, random control sample of 77 biopsy samples in 75 inpatients during the same period was reviewed (C).
Results: All but 1 TJLBx (C group) were technically successful (99%). One major (ISP) and 5 minor complications occurred (H = 3, ISP = 1, C = 1). There were 3 inadequate specimens (6.4%) in the H group, 4 in the ISP group (12.9%), and 4 in the C group (5.2%) (p = NS). No organisms were isolated in any ISP biopsy samples (yield 0%).
Conclusion: When ISP is requested in BMT recipients, biopsy yields were lower, for unclear reasons possibly relating to degree of liver injury. ISP adds no useful positive information over histology alone. The value of negative cultures in this population is unclear.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00270-013-0672-5 | DOI Listing |
Immun Inflamm Dis
January 2025
Department of Clinical Laboratory, the Second Affiliated Hospital of Anhui Medical University, Hefei, China.
Backgrounds And Aims: CD8+T cells are crucially associated with the fight against hepatitis B virus (HBV) infection. CD161 has been shown to express remarkably on HCV-specific CD8+T cells. However, the accurate function of CD161+CD8+T cells in HBV immunity or pathogenesis remains undetermined.
View Article and Find Full Text PDFJ Biochem Mol Toxicol
January 2025
Department of Medical Biochemistry, Faculty of Medicine, Kahramanmaraş Sütçü İmam University, Kahramanmaraş, Turkey.
Neurodegenerative diseases are significant health concerns that have a profound impact on the quality and duration of life for millions of individuals. These diseases are characterized by pathological changes in various brain regions, specific genetic mutations associated with the disease, deposits of abnormal proteins, and the degeneration of neurological cells. As neurodegenerative disorders vary in their epidemiological characteristics and vulnerability of neurons, treatment of these diseases is usually aimed at slowing disease progression.
View Article and Find Full Text PDFBreast Cancer Res Treat
January 2025
Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Bioinformatics
January 2025
Department of Pathology and Department of Immunobiology, Yale School of Medicine.
Summary: With the increased reliance on multi-omics data for bulk and single cell analyses, the availability of robust approaches to perform unsupervised learning for clustering, visualization, and feature selection is imperative. We introduce nipalsMCIA, an implementation of multiple co-inertia analysis (MCIA) for joint dimensionality reduction that solves the objective function using an extension to Non-linear Iterative Partial Least Squares (NIPALS). We applied nipalsMCIA to both bulk and single cell datasets and observed significant speed-up over other implementations for data with a large sample size and/or feature dimension.
View Article and Find Full Text PDFCell Mol Biol (Noisy-le-grand)
January 2025
Université Joseph KI-ZERBO, Laboratoire de Biologie Moléculaire et de Génétique (LABIOGENE), 03 BP 7021 Ouagadougou 03, Burkina Faso.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!